Randomized Phase II Study of Everolimus (E) versus Everolimus plus Bevacizumab (E+B) in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pNET), CALGB 80701 (Alliance)
- Citation:
- Pancreas vol 45 (3) abstr C23
- Meeting Instance:
- NANETS 2015
- Year:
- 2016
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3473
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, CA31946, CA025224
- Corr. Author:
- Authors:
- Matthew H. Kulke Donna Niedzwiecki Nathan R. Foster Briant Fruth Pamela L. Kunz Hagen Kennecke Edward M. Woli Alan P. Venook
- Networks:
- CA136, LAPS-CT018, LAPS-MA036, LAPS-MN026, PCRC
- Study
- CALGB-80701
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: